Cellectar Biosciences Inc (CLRB)

NASDAQ
1.1200
+0.0300(+2.75%)
  • Volume:
    693,006
  • Bid/Ask:
    1.0700/1.1100
  • Day's Range:
    1.0823 - 1.1481

CLRB Overview

Prev. Close
1.09
Day's Range
1.0823-1.1481
Revenue
-
Open
1.1
52 wk Range
1.01-2.97
EPS
-0.66
Volume
693,006
Market Cap
59.05M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
318,757
P/E Ratio
-
Beta
1.66
1-Year Change
-21.13%
Shares Outstanding
52,726,278
Next Earnings Date
Nov 16, 2021
What is your sentiment on Cellectar Biosciences Inc?
or
Market is currently closed. Voting is open during market hours.

Cellectar Biosciences Inc News

Cellectar Biosciences Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuySellStrong Sell
Technical IndicatorsStrong BuyStrong BuyBuyStrong SellStrong Sell
SummaryStrong BuyStrong BuyStrong BuyStrong SellStrong Sell

Cellectar Biosciences Inc Company Profile

Cellectar Biosciences Inc Company Profile

Employees
11

Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131, which is in Phase II clinical study in patients with relapsed or refractory (R/R) Waldenstrom’s macroglobulinemia (WM) and B-cell malignancies; and Phase IIB clinical study in r/r multiple myeloma (MM) patients, as well as Phase I study for various pediatric cancers, R/R head and neck cancers, and R/R MM. The company also develops CLR 1900, a PDC chemotherapeutic program that is in the preclinical stage to treat solid tumors. It has collaborative PDC programs with Avicenna Oncology GMBH to develop CLR 2000 Series; Orano Med to develop CLR 12120 Series; and IntoCell Inc. Cellectar Biosciences, Inc. was founded in 2002 and is headquartered in Florham Park, New Jersey.

Read More
  • why this isnt dropping near offering price 1,35?
    0
    • The company has only 8 employees and has net losses. Buy it only for trading to get a profit from -25% to -15% you may get a 10% profit but you have to be quick. You may also have in mind that such a small company may bankrupt if the losses increase.
      1
      • CLRB shown positive study for mm. It went up till 4.76 during pre-market. It then turned south throughout. Any thoughts or reasons?
        0
        • HELLO hello Mr. Chia., i am thinking to invest in Cellestar do you think is a good idea please ? what is your opinion please ?
          1
      Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
      Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.